Amount$57M
Post-money valuation$75M
SeriesSeries C
AnnouncedSep 21, 2020
Time since last round941 mo
SectorHealthcare, Drug Development, Genomics, Next Generation Sequencing, Biotech, Oncology, Clinical
Sub-sectorDeep Learning, Machine Learning
Solid
A solid round with healthy fundamentals.
Round size vs peers
In line with the typical Series C round.
Syndicate size
Party round (11 investors) — diffuse ownership and signal.
Insider conviction
11 existing investors re-upped — insiders doubling down.
Investor track record
Mostly newer or unproven managers.
Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.
vs. Series C rounds (999)
Round size distribution58th pct
smaller Series C roundslarger
Post-money valuation1th pct
$29Mthis round: $75M$3B
vs. Healthcare, Drug Development, Genomics, Next Generation Sequencing, Biotech, Oncology, Clinical (4)
Round size in sector75th pct
$6Mthis round: $57M$75M
